Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,692
datasets available to search
ShareScore release 0.9.0
Dataset results
2,692 results for “medicinal”
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Bosnia and Herzegovina
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Bosnia and Herzegovina. The presence of unauthorised substances, residues of veterinary medicinal products or chemical contaminants in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Regulation (EC) 1881/2006 lays down the maximum limits for the presence of certain contaminants in animal products. Council Directive 96/23/EC lays down measures to monitor certain substances and residues thereof, mainly veterinary medicinal products, in live animals and animal products. Additionally, Commission Decision 97/747/EC lays down levels and frequencies of sampling for certain animal products.</p> <p>The chemical monitoring data collected and published by EFSA include the analytical results provided by EU Member States and three pre-accession countries: Bosnia-Herzegovina, Montenegro, North Macedonia and Serbia.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the monitoring plan, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances or products mean substances or products prohibited under European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2020 – Veterinary Office of Bosnia and Herzegovina</p> <p>VMPR_2018 – Veterinary Office of Bosnia and Herzegovina</p>
Pharmaceutical advertising and the consumption of over the counter (OTC) medicines in users of the Superfar drugstore in Barrios Altos - Cercado de Lima, 2022.
<p>To determine the relationship between pharmaceutical advertising and the consumption of over-the-counter (OTC) medicines in users of the SUPERFAR drugstore in barrios altos -cercado de lima, 2022.</p>
Datos para: Análisis de la producción científica pinareña en el área Medicine en Scopus entre 2017 y 2021
<p><strong>Introducción: </strong>La evaluación de la producción científica institucional constituye una herramienta de gran valor para trazar estrategias guiadas a una mejor cultura de investigación y publicación.</p> <p><strong>Objetivo: </strong>Caracterizar la producción científica pinareña en el área <em>Medicine</em> en Scopus.</p> <p><strong>Métodos:</strong> Estudio observacional, descriptivo, bibliométrico de los artículos con autoría pinareña en revistas indexadas en Scopus entre 2017 y 2021. El universo estuvo compuesto por 86 artículos. Se empleó una estrategia de búsqueda para recuperar la información, Zotero y Bibexcel para la normalización de metadatos y VOSviewer para generar los mapas de co-ocurrencia de términos.</p> <p><strong>Resultados:</strong> Se encontró que el año más productivo fue el 2020 donde se publicaron el 31,33 % de los artículos; predominaron de artículos originales (82,56 %). El 87,24 % de los artículos se publicaron en revistas nacionales, donde el 30,24 % se publicaron en la Revista Cubana de Medicina General Integral. 27 artículos mostraron colaboración internacional, de ellos el 33,35 % provenían de Ecuador. El análisis de coocurrencia de términos permitió identificar 69 términos con más de 4 menciones, organizándolos en 17 clúster. Se encontraron como instituciones más productivas a la Universidad de Ciencias Médicas de Pinar del Río (40,69 %) y el Policlínico Universitario “Pedro Borras Astronga” (13,95 %).</p> <p><strong>Conclusiones:</strong> existió una baja producción científica pinareña en el área <em>Medicine</em> en Scopus, caracterizada por un mayor número de artículos originales y publicación de artículos en revistas nacionales. Se evidenció la existencia de cooperación internacional, así como la universidad como líder en producción científica. </p>
Home and hub: pet trade and traditional medicine impact reptile populations in source locations and destinations
<p>The pet trade and Traditional Chinese Medicine (TCM) consumption are major drivers of global biodiversity loss. Tokay geckos (<em>Gekko gecko</em>) are among the most traded reptile species worldwide. In Hong Kong, pet and TCM markets sell tokay geckos while wild populations also persist. To clarify connections between trade sources and destinations, we compared genetics and stable isotopes of wild tokays in local and nonlocal populations to dried individuals from TCM markets across Hong Kong. We found that TCM tokays are likely not of local origin. Most wild tokays were related to individuals in South China, indicating a probable natural origin. However, two populations contained individuals more similar to distant populations, indicating pet trade origins. Our results highlight the complexity of wildlife trade impacts within trade hubs. Such trade dynamics complicate local legal regulation when endangered species are protected, but the same species might also be non-native and possibly damaging to the environment.</p>
Knowledge and attitude of the people in San Juan de Miraflores towards the disposal of medicines.
<p><strong>Objective:</strong> To evaluate the relationship between the level of knowledge and attitudes on how to dispose of medicines in households in the district of San Juan de Miraflores.</p> <p><strong>Método:</strong> Hypothetical-deductive, quantitative approach, applied type and non-experimental, observational design, for which 385 households in the district of San Juan de Miraflores were surveyed.</p> <p><strong>Results:</strong> 48.3% of the respondents have an average level of knowledge of how to dispose of medicines. 93.2% of the respondents have a positive attitude towards the disposal of medicines, and there is a relationship between the level of knowledge and attitude towards the disposal of medicines (P-value = 0.000).</p> <p><strong>Conclusion:</strong> Increased knowledge is associated with a better attitude to the disposal of medicines.</p>
Measuring platelet function: new strategies for precision medicine to prevent thrombosis - Prof Jon Gibbins (University of Reading)
<p>This video is the third talk from our two day Future Blood Testing: Challenges & Opportunities Event that took place on the 13/09/2022.</p> <p>Measuring platelet function: new strategies for precision medicine to prevent thrombosis - Prof Jon Gibbins (University of Reading).</p> <p>Bio: Jon Gibbins is Professor of Cell Biology within the School of Biological Sciences at the University and is Director of the Institute for Cardiovascular and Metabolic Research. He is a graduate of the University, obtaining a degree in Pathobiology with Chemistry in 1991 and a PhD in Molecular Endocrinology in 1995. Following a period of postdoctoral research at the Oxford University, he returned to Reading in 1998 as a lecturer. Jon has established an internationally leading research group that studies blood clotting, with a particular focus on the development of more effective clinical strategies for the prevention and treatment of heart attacks and strokes, and thrombosis associated with infection. Jon values greatly working in an active, engaging and successful school, in which all aspects of biology are represented, and he champions cross-disciplinary working to approach today’s most challenging and pressing questions in new ways. He believes strongly in widening participation and improving levels of equity, diversity and inclusion across our institution.</p> <p>Further details on this event can be found at: https://futurebloodtesting.org/event/13-14-09-2022/</p> <p>This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1</p> <p>YouTube Link: https://youtu.be/8vJZ_WO-dvk</p>
Preventative medicine? Examining prophylactic effects of a sunflower pollen diet in Bombus impatiens
<p>The widespread decline of pollinator populations is of concern for both natural and agricultural ecosystems. Pathogens have been identified as a major contributor to the decline of some bee species, making understanding host-pathogen dynamics a crucial area of research. Sunflower pollen (<em>Helianthus annuus</em>) dramatically and consistently reduces infection by a prevalent gut pathogen, <em>Crithidia bombi</em>, in the common eastern bumble bee (<em>Bombus impatiens</em>), when consumed by bees post-infection, but we do not know if sunflower can confer protection when consumed before exposure. We asked whether feeding bumble bees sunflower pollen diets before pathogen exposure decreases <em>Crithidia</em> infection compared to buckwheat pollen (<em>Fagopyrum esculentum</em>). Buckwheat pollen was used as a comparison since it has a similar protein concentration as sunflower pollen, but results in high <em>Crithidia</em> counts when consumed post-infection. Bumble bees were fed sunflower or buckwheat pollen for seven days, inoculated with <em>Crithidia</em>, and then fed a wildflower pollen control diet for seven more days before assessing infection. We found that consuming a sunflower pollen diet before inoculation did not reduce <em>Crithidia</em> cell counts compared to buckwheat pollen. Further, bumble bee survival and consumption of sucrose solution and pollen did not differ between these diets. The results show no evidence of sunflower pollen providing prophylactic resistance against <em>Crithidia bombi </em>infection, indicating that the timing at which sunflower pollen is consumed relative to exposure has important consequences for infection.</p>
FIGURE 6. Macrobdella ditetra Moore, 1953 in Range Extension for the Elusive New England Medicinal Leech, Macrobdella sestertia Whitman, 1886 (Hirudinida: Macrobdellidae), in South Carolina, U.S.A., with Notes on Morphology, Coloration, and Biology
FIGURE 6. Macrobdella ditetra Moore, 1953 (CASIZ 224103) feeding on Lithobates sphenocephalus (Cope, 1886); arrows point to the leech.
FIGURE 4 in Range Extension for the Elusive New England Medicinal Leech, Macrobdella sestertia Whitman, 1886 (Hirudinida: Macrobdellidae), in South Carolina, U.S.A., with Notes on Morphology, Coloration, and Biology
FIGURE 4. Unusual overlapping annuli (annuli 48–49) observed on one specimen of Macrobdella sestertia (ChM IO7).
FIGURE 2. Macrobdella sestertia Whitman, 1886 in Range Extension for the Elusive New England Medicinal Leech, Macrobdella sestertia Whitman, 1886 (Hirudinida: Macrobdellidae), in South Carolina, U.S.A., with Notes on Morphology, Coloration, and Biology
FIGURE 2. Macrobdella sestertia Whitman, 1886 from Sleepy Creek, Edgefield Co., South Carolina (CASIZ 224101). Specimens were photographed alive on 1 August 2008.
FIGURE 3 in Range Extension for the Elusive New England Medicinal Leech, Macrobdella sestertia Whitman, 1886 (Hirudinida: Macrobdellidae), in South Carolina, U.S.A., with Notes on Morphology, Coloration, and Biology
FIGURE 3. Distribution of Macrobdella sestertia Whitman, 1886 in Edgefield Co., South Carolina, USA.
FIGURE 8 in Range Extension for the Elusive New England Medicinal Leech, Macrobdella sestertia Whitman, 1886 (Hirudinida: Macrobdellidae), in South Carolina, U.S.A., with Notes on Morphology, Coloration, and Biology
FIGURE 8. Field notes for Macrobdella collections at Northwood Lake (aka Suncook Pond), Rockingham Co., New Hampshire on 3 June 1938 by Reeve M. Bailey and James A. Oliver. Courtesy of Fish Division, University of Michigan Museum of Zoology (UMMZ).
Fig. 8 in Comparative cranial osteology of subadult eucentrosauran ceratopsid dinosaurs from the Two Medicine Formation, Montana, indicates sequence of ornamentation development and complex supraorbital ontogenetic change
Fig. 8. Size comparison of squamosal versus face in Einiosaurus procurvicornis Sampson, 1995, subadult MOR 456 8-8-87-1 (A) and MOR 456 8-9-6-1, holotype (B, mirrored); squamosal superimposed in B. C. Outline of MOR 456 8-8-87-1 (red) superimposed over outline of MOR 456 8-9-6-1 (grey). D. Outline of MOR 591 (blue) superimposed over outline of MOR 456 8-9-6-1 (grey). Outlines aligned by otic notch.
Fig. 5 in Comparative cranial osteology of subadult eucentrosauran ceratopsid dinosaurs from the Two Medicine Formation, Montana, indicates sequence of ornamentation development and complex supraorbital ontogenetic change
Fig. 5. Lateral views of jugals of Einiosaurus procurvicornis Sampson, 1995, MOR 456 8-8-87-1 (A) and eucentrosauran (Einiosaurus procurvicornis or Achelousaurus horneri Sampson, 1995), MOR 591 (B, mirrored), from the Campanian Two Medicine Formation, Montana, USA. Arrow indicates epijugal.
Fig. 6 in Comparative cranial osteology of subadult eucentrosauran ceratopsid dinosaurs from the Two Medicine Formation, Montana, indicates sequence of ornamentation development and complex supraorbital ontogenetic change
Fig. 6. Ontogenetic series of supraorbital ornamentation of Einiosaurus procurvicornis Sampson, 1995 from the Campanian Canyon Bonebed, Two Medicine Formation (TM-046), Montana, USA. A, B. Juvenile, MOR 456 8-10-87-20 (A) and MOR 456 8-8-87-19 (B). C, D. Early subadult, MOR 456 8-9-7-3 (C) and MOR 456 2020-C-1 (D). E, F. Late subadult, MOR 456 8-8-87-1 (E) and MOR 456 8-23-87 (F). G, H. Young adult, MOR 456 2020-C-2 (G) and MOR 456 8-9-6-1 (H). B and D are mirrored. All specimens in anterior view, lateral is to the right in A–D, G, H; E, entire skull width; F, lateral is to the left.
Fig. 4 in Comparative cranial osteology of subadult eucentrosauran ceratopsid dinosaurs from the Two Medicine Formation, Montana, indicates sequence of ornamentation development and complex supraorbital ontogenetic change
Fig. 4. Anterior views of supraorbital ornamentation of Einiosaurus procurvicornis Sampson, 1995, MOR 456 8-8-87-1 (A) and eucentrosauran Einiosaurus procurvicornis or Achelousaurus horneri Sampson, 1995), MOR 591 (B), from the Campanian Two Medicine Formation, Montana, USA.
Fig. 7 in Comparative cranial osteology of subadult eucentrosauran ceratopsid dinosaurs from the Two Medicine Formation, Montana, indicates sequence of ornamentation development and complex supraorbital ontogenetic change
Fig. 7. Ontogenetic series of supraorbital ornamentation of Einiosaurus procurvicornis Sampson, 1995 from the Campanian Canyon Bonebed (TM-046), Montana, USA. A, B. Juvenile, MOR 456 8-10-87-20 (A) and MOR 456 8-8-87-19 (B). C, D. Early subadult, MOR 456 8-9-7-3 (C) and MOR 456 2020- C-1 (D). E, F. Late subadult, MOR 456 8-8-87-1 (E) and MOR 456 8-23-87 (F). G, H. Young adult, MOR 456 2020-C-2 (G) and MOR 456 8-9-6-1 (H). B, D–G are mirrored. All specimens in lateral view, anterior is to the left in all images.
Fig. 3 in Comparative cranial osteology of subadult eucentrosauran ceratopsid dinosaurs from the Two Medicine Formation, Montana, indicates sequence of ornamentation development and complex supraorbital ontogenetic change
Fig. 3. Right lateral views of supraorbital ornamentation of Einiosaurus procurvicornis Sampson, 1995, MOR 456 8-8-87-1 (A) and eucentrosauran (Einiosaurus procurvicornis or Achelousaurus horneri Sampson, 1995), MOR 591 (B) from the Campanian Two Medicine Formation, Montana, USA.
Fig. 2 in Comparative cranial osteology of subadult eucentrosauran ceratopsid dinosaurs from the Two Medicine Formation, Montana, indicates sequence of ornamentation development and complex supraorbital ontogenetic change
Fig. 2. Right lateral views of nasal horncores of Einiosaurus procurvicornis Sampson, 1995, MOR 456 8-8-87-1 (A) and eucentrosauran (Einiosaurus procurvicornis or Achelousaurus horneri Sampson, 1995), MOR 591 (B, mirrored), from the Campanian Two Medicine Formation, Montana, USA.
Fig. 1 in Comparative cranial osteology of subadult eucentrosauran ceratopsid dinosaurs from the Two Medicine Formation, Montana, indicates sequence of ornamentation development and complex supraorbital ontogenetic change
Fig. 1. Lateral views of articulated crania of subadult eucentrosaurans from the Campanian Two Medicine Formation, Montana, USA. A. Einiosaurus procurvicornis Sampson, 1995, MOR 456 8-8-87-1. B. Eucentrosauran (Einiosaurus procurvicornis or Achelousaurus horneri Sampson, 1995), MOR 591. Photographs (A1 and B1), osteological line drawings (A2, B2). Face of MOR 591 mirrored, with parietosquamosal frill superimposed. The contact outlines between the postorbital, jugal, and squamosal in A2 are estimated due to lack of externally visible sutures and may appear different from MOR 591 due to some breaks and gaps. P4–P7, parietal processes.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.